Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Gilead Sciences Presents New 5-Year Data Reinforcing Biktarvy As Long-Term HIV Treatment; Investigational Dosing Frequencies Aim To Expand Options And Address Unmet Needs; Key Findings Presented At AIDS 2024 Conference Highlight Innovative HIV Treatment Portfolio And Research Pipeline

Author: Benzinga Newsdesk | July 25, 2024 09:16am

Posted In: GILD